Cipta Sarana Medika Tbk. vs Satu Visi Putra Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Satu Visi Putra Tbk. trades at Rp925 (market cap 2.94T, 977.1K 24h volume). The key difference: Satu Visi Putra Tbk. is far larger — about 18.3× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 977.1K). Which is the better fit depends on your goals.
| DKHH | VISI | |
|---|---|---|
Market Cap | 160.67B | 2.94T |
Volume | 14.05M | 977.1K |
Lot | 140.49K | 9.77K |
Turnover | 899.67M | 914.21M |
Average Price | 64.04 | 935.64 |
Value | 899.67M | 914.21M |
Indicative Equilibrium Price | 64 | 925 |
Indicative Equilibrium Volume | 100 | 360 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Satu Visi Putra Tbk (the Entity) was established based on Deed No. 16, dated February 14, 2018 of Soeprayitno, S.H., notary in Surabaya. The Entity started its commercial operation in 2018.
Read more on VISI →